Stock listing
NASDAQ:XFOR X4 Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of X4 Pharmaceuticals, Inc.
Follow X4 Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:XFOR
$3.35 USD -0.01 (-0.3%)
Close on Oct 30, 2026
- Day range
- $3.19 – $3.41 USDOct 30, 2026
- Volume
- 706,226 sharesOct 30, 2026
- Market cap
- $332.1M USDAt the close on Oct 30, 2026 · price × 99.15M shares outstanding
- 52-week range
- $2.43 – $4.83 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $2.95M USDMedian day 650,350 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:XFOR · Home | $3.35 USD | -0.01 (-0.3%) | 706,226 | $3.33 | $3.41 | $3.19 | $3.36 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:XFOR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.35 | -0.01 | -0.3% | $3.33 | $3.41 | $3.19 | 706,226 | |
| $3.36 | +0.01 | +0.3% | $3.39 | $3.49 | $3.05 | 908,046 | |
| $3.35 | +0.10 | +3.1% | $3.24 | $3.36 | $3.14 | 534,947 | |
| $3.25 | 0.00 | 0.0% | $3.20 | $3.30 | $3.05 | 1,607,224 | |
| $3.25 | +0.01 | +0.3% | $3.265 | $3.30 | $3.14 | 701,646 | |
| $3.24 | +0.04 | +1.3% | $3.16 | $3.25 | $3.02 | 536,600 | |
| $3.20 | +0.19 | +6.3% | $2.99 | $3.28 | $2.96 | 591,800 | |
| $3.01 | -0.01 | -0.3% | $3.02 | $3.12 | $2.875 | 406,900 | |
| $3.02 | +0.27 | +9.8% | $2.79 | $3.07 | $2.77 | 593,300 | |
| $2.75 | +0.16 | +6.2% | $2.60 | $2.82 | $2.58 | 603,000 | |
| $2.59 | -0.05 | -1.9% | $2.64 | $2.71 | $2.52 | 967,600 | |
| $2.64 | +0.19 | +7.8% | $2.48 | $2.655 | $2.475 | 549,800 | |
| $2.45 | -0.15 | -5.8% | $2.54 | $2.55 | $2.43 | 705,700 | |
| $2.60 | -0.22 | -7.8% | $2.81 | $2.83 | $2.59 | 439,500 | |
| $2.82 | -0.09 | -3.1% | $2.89 | $2.93 | $2.81 | 404,300 | |
| $2.91 | +0.12 | +4.3% | $2.83 | $2.965 | $2.815 | 541,200 | |
| $2.79 | -0.02 | -0.7% | $2.77 | $2.81 | $2.70 | 836,500 | |
| $2.81 | +0.04 | +1.4% | $2.74 | $2.86 | $2.70 | 435,400 | |
| $2.77 | -0.13 | -4.5% | $2.90 | $2.90 | $2.70 | 642,500 | |
| $2.90 | +0.07 | +2.5% | $2.88 | $2.935 | $2.73 | 698,100 | |
| $2.83 | 0.00 | 0.0% | $2.86 | $2.86 | $2.745 | 911,400 | |
| $2.83 | -0.07 | -2.4% | $2.89 | $2.95 | $2.82 | 501,500 | |
| $2.90 | 0.00 | 0.0% | $2.93 | $2.935 | $2.845 | 1,764,600 | |
| $2.90 | -0.115 | -3.8% | $3.01 | $3.055 | $2.895 | 1,709,300 | |
| $3.015 | +0.005 | +0.2% | $2.996 | $3.04 | $2.81 | 838,300 | |
| $3.01 | +0.01 | +0.3% | $2.98 | $3.083 | $2.965 | 1,856,500 | |
| $3.00 | -0.11 | -3.5% | $3.10 | $3.10 | $2.955 | 973,600 | |
| $3.11 | -0.32 | -9.3% | $3.41 | $3.42 | $3.035 | 2,309,100 | |
| $3.43 | -0.065 | -1.9% | $3.52 | $3.57 | $3.40 | 922,400 | |
| $3.495 | -0.085 | -2.4% | $3.58 | $3.58 | $3.455 | 444,400 | |
| $3.58 | +0.08 | +2.3% | $3.48 | $3.635 | $3.48 | 1,543,400 | |
| $3.50 | -0.01 | -0.3% | $3.56 | $3.585 | $3.41 | 635,100 | |
| $3.51 | -0.11 | -3.0% | $3.63 | $3.65 | $3.355 | 973,300 | |
| $3.62 | 0.00 | 0.0% | $3.60 | $3.64 | $3.31 | 2,081,100 | |
| $3.62 | +0.12 | +3.4% | $3.51 | $3.711 | $3.47 | 1,017,900 | |
| $3.50 | +0.10 | +2.9% | $3.44 | $3.55 | $3.24 | 1,252,900 | |
| $3.40 | -0.20 | -5.6% | $3.60 | $3.675 | $3.31 | 2,570,100 | |
| $3.60 | +0.095 | +2.7% | $3.50 | $3.67 | $3.45 | 1,402,200 | |
| $3.505 | -0.535 | -13.2% | $4.00 | $4.125 | $3.19 | 2,322,400 | |
| $4.04 | 0.00 | 0.0% | $4.01 | $4.08 | $4.00 | 168,200 | |
| $4.04 | 0.00 | 0.0% | $4.06 | $4.069 | $3.99 | 409,400 | |
| $4.04 | -0.03 | -0.7% | $4.10 | $4.17 | $4.015 | 361,000 | |
| $4.07 | +0.03 | +0.7% | $3.97 | $4.11 | $3.97 | 203,800 | |
| $4.04 | 0.00 | 0.0% | $4.02 | $4.10 | $4.00 | 245,900 | |
| $4.04 | -0.19 | -4.5% | $4.22 | $4.23 | $4.00 | 356,200 | |
| $4.23 | +0.06 | +1.4% | $4.18 | $4.39 | $4.145 | 597,200 | |
| $4.17 | +0.01 | +0.2% | $4.16 | $4.23 | $4.075 | 707,100 | |
| $4.16 | +0.11 | +2.7% | $4.05 | $4.18 | $3.995 | 390,755 | |
| $4.05 | +0.01 | +0.2% | $4.03 | $4.095 | $3.94 | 299,166 | |
| $4.04 | +0.01 | +0.2% | $4.05 | $4.175 | $4.005 | 1,219,600 | |
| $4.03 | -0.13 | -3.1% | $4.12 | $4.22 | $3.99 | 561,200 | |
| $4.16 | -0.05 | -1.2% | $4.25 | $4.35 | $4.14 | 405,900 | |
| $4.21 | -0.09 | -2.1% | $4.27 | $4.32 | $4.145 | 362,100 | |
| $4.30 | +0.08 | +1.9% | $4.20 | $4.335 | $4.13 | 1,095,400 | |
| $4.22 | -0.07 | -1.6% | $4.26 | $4.33 | $4.05 | 840,900 | |
| $4.29 | 0.00 | 0.0% | $4.28 | $4.455 | $4.19 | 1,127,800 | |
| $4.29 | +0.01 | +0.2% | $4.29 | $4.55 | $4.245 | 1,040,900 | |
| $4.28 | +0.03 | +0.7% | $4.19 | $4.425 | $4.13 | 1,079,900 | |
| $4.25 | -0.39 | -8.4% | $4.60 | $4.633 | $4.21 | 658,200 | |
| $4.64 | +0.47 | +11.3% | $4.26 | $4.82 | $4.215 | 1,597,000 | |
| $4.17 | +0.02 | +0.5% | $4.15 | $4.26 | $4.065 | 447,800 | |
| $4.15 | -0.14 | -3.3% | $4.26 | $4.28 | $4.08 | 372,600 | |
| $4.29 | +0.20 | +4.9% | $4.10 | $4.33 | $4.10 | 604,700 | |
| $4.09 | +0.11 | +2.8% | $4.01 | $4.10 | $3.965 | 364,100 | |
| $3.98 | -0.02 | -0.5% | $4.00 | $4.05 | $3.87 | 415,500 | |
| $4.00 | 0.00 | 0.0% | $3.96 | $4.23 | $3.96 | 504,400 |
- Ticker
- NASDAQ:XFOR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
X4 Pharmaceuticals Highlights Clinical Progress and Market Opportunity for Mavorixafor in Primary Chronic Neutropenia During Virtual Investor Day
Latest deck · Oct 29, 2026
Investor Day (October 2026)
Investor day · 34 slides
Calls
Replays
X4 Pharmaceuticals (NASDAQ:XFOR) Q1 2025 Earnings Call
Wed, Apr 30, 2025 · 10:30 PM ET
Watch TranscriptX4 Pharmaceuticals (NASDAQ:XFOR) Q4 2024 Earnings Call
Tue, Mar 25, 2025 · 8:30 AM ET
Watch TranscriptX4 Pharmaceuticals (NASDAQ:XFOR) Q3 2024 Earnings Call
Wed, Nov 13, 2024 · 8:00 AM ET
Watch Transcript
Latest news
X4 Pharmaceuticals Highlights Clinical Progress and Market Opportunity for Mavorixafor in Primary Chronic Neutropenia During Virtual Investor Day
Oct 29, 2026
Closed $3.35 (-0.3%) on Oct 30, 2026
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
Oct 9, 2026
Closed $2.91 (+4.3%) on Oct 9, 2026
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
Oct 8, 2026
Closed $2.79 (-0.7%) on Oct 8, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026
Closed $2.83 (0.0%) on Oct 2, 2026
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
Sep 9, 2026
Closed $3.60 (+2.7%) on Sep 9, 2026
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
Sep 8, 2026
Closed $3.51 (-13.2%) on Sep 8, 2026
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 6, 2026
Closed $4.64 (+11.3%) on Aug 7, 2026
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Closed $4.03 (+0.8%) on May 27, 2026
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
Closed $4.38 (+4.3%) on May 6, 2026
Decks
Investor Day (October 2026)
Investor day · 34 slides · Oct 29, 2026
Investor Presentation (October 2026)
Investor deck · 20 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 20 slides · Sep 9, 2026
Investor Presentation (May 2025)
Investor deck · 32 slides · May 1, 2025
X4 Pharmaceuticals, Inc. on 6ix
- News releases
- 18 in the last 12 months · 125 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 19 calls with a replay · 19 with a transcript · latest May 1, 2025
- Decks
- 23 decks · latest Oct 29, 2026
Where X4 Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XFOR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:XFOR | BOATS | United States | USD |
| gettex:48Q0 | gettex | Germany | EUR |
| Lang & Schwarz:A3E4QR | Lang & Schwarz | Germany | EUR |
| Frankfurt:48Q0 | Frankfurt | Germany | EUR |
| LS Exchange:A3E4QR | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about X4 Pharmaceuticals, Inc.